Abstract
Polycystic ovarian syndrome (PCOS) is the most common cause of hyperandrogenism in women and adolescent girls. A 1990 consensus conference of the United States Institutes of Health identified key features for the diagnosis of PCOS: hyperandrogenism, menstrual dysfunction, clinical evidence of hyperandrogenism, and the exclusion of congenital adrenal hyperplasia. Probable criteria for PCOS included insulin resistance and perimenarchal onset. Fleischman and Mansfield discuss the diagnosis and treatment of PCOS and insulin resistance.
Author supplied keywords
- Cardiovascular Diseases -- etiology
- Diabetes Mellitus, Type 2 -- etiology
- Female
- Humans
- Hyperandrogenism -- etiology
- Hyperlipidemias -- etiology
- Infertility, Female -- etiology
- Insulin
- Insulin Resistance
- Life Style
- Medical Sciences--Pediatrics
- Medical diagnosis
- Medical treatment
- Mineralocorticoid Receptor Antagonists
- Mineralocorticoid Receptor Antagonists -- therapeu
- Obesity -- etiology
- Polycystic Ovary Syndrome -- complications
- Polycystic Ovary Syndrome -- diagnosis
- Polycystic Ovary Syndrome -- therapy
- Reproductive system
- Spironolactone
- Spironolactone -- therapeutic use
- Treatment Outcome
- Women
Cite
CITATION STYLE
Fleischman MD, A., & Mansfield MD, J. (2005). Diagnosis and Treatment of Polycystic Ovarian Syndrome and Insulin Resistance. Pediatric Annals, 34(9), 733-738,741-742. Retrieved from https://queens.ezp1.qub.ac.uk/login?url=https://www.proquest.com/docview/217554677?accountid=13374 http://resolver.ebscohost.com/openurl?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&rfr_id=info:sid/ProQ%3Aeducation&rft_val_fmt=info:ofi/fmt:kev:mtx:journ
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
